Cargando…

Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capaci...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zhaomin, Zhang, Yi, Pan, Yang, Zhang, Daitao, Zhang, Lei, Wang, Quanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274759/
https://www.ncbi.nlm.nih.gov/pubmed/35862506
http://dx.doi.org/10.1515/mr-2021-0024
_version_ 1784745358115471360
author Feng, Zhaomin
Zhang, Yi
Pan, Yang
Zhang, Daitao
Zhang, Lei
Wang, Quanyi
author_facet Feng, Zhaomin
Zhang, Yi
Pan, Yang
Zhang, Daitao
Zhang, Lei
Wang, Quanyi
author_sort Feng, Zhaomin
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly.
format Online
Article
Text
id pubmed-9274759
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-92747592022-07-12 Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy Feng, Zhaomin Zhang, Yi Pan, Yang Zhang, Daitao Zhang, Lei Wang, Quanyi Med Rev (Berl) Review The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly. De Gruyter 2022-04-28 /pmc/articles/PMC9274759/ /pubmed/35862506 http://dx.doi.org/10.1515/mr-2021-0024 Text en © 2022 Zhaomin Feng et al., published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Review
Feng, Zhaomin
Zhang, Yi
Pan, Yang
Zhang, Daitao
Zhang, Lei
Wang, Quanyi
Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
title Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
title_full Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
title_fullStr Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
title_full_unstemmed Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
title_short Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
title_sort mass screening is a key component to fight against sars-cov-2 and return to normalcy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274759/
https://www.ncbi.nlm.nih.gov/pubmed/35862506
http://dx.doi.org/10.1515/mr-2021-0024
work_keys_str_mv AT fengzhaomin massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy
AT zhangyi massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy
AT panyang massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy
AT zhangdaitao massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy
AT zhanglei massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy
AT wangquanyi massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy